Publications and Presentations
Fernandez NB, Sosa SM, Roberts JT, Recouvreux MS, Rocha-Viegas L, Christenson JL, Spoelstra NS, Couto FL, Raimondi AR, Richer JK, Rubinstein N (2023) RUNX1 is regulated by androgen receptor to promote cancer stem markers and chemotherapy resistance in triple negative breast cancer. Cells 12: 444. PMID: 36766786
Christenson JL, Williams MW, Richer JK (2022) The underappreciated role of resident cell populations in metastatic progression: Contributions of the lung alveolar epithelium. American Journal of Physiology: Cell Physiology 323: C1777. PMID: 36252127
Camp FA, Brunetti TM, Williams MM, Christenson JL, Shreekanth V, Costello JC, Hay ZLZ, Kedl RM, Richer JK, Slansky JE (2022) Antigens expressed by breast cancer cells undergoing EMT stimulate cytotoxic CD8+ T cell immunity. Cancers 14: 4397. PMID: 36139558
Hanamura T, Christenson JL, O’Neill KI, Rosas E, Spoelstra NS, Williams MM, Richer JK (2021) Secreted indicators of androgen receptor activity in breast cancer pre-clinical models. Breast Cancer Research 23: 102. PMID: 34736512
Williams M, Hafeez S, Christenson J, O’Neill K, Hammond N, Richer J (2021) Reversing an oncogenic epithelial-to-mesenchymal transition program in breast cancer reveals actionable immune suppressive pathways. Pharmaceuticals (Basel) 14: 1122. PMID: 34832904
Christenson JL, O’Neill KI, Williams MM, Spoelstra N, Jones KL, Trahan GD, Reese JM, Van Patten E, Elias, AD, Eisner JR, Richer JK (2021) Activity of combined androgen receptor antagonism and cell cycle inhibition in androgen receptor-positive triple-negative breast cancer. Molecular Cancer Therapeutics 20: 1062-1071. PMID: 33722849
Williams, MM, Christenson, JL, O’Neill, KI, Hafeez, SA, Ihle, CL, Spoelstra, NS, Slansky, JE, and Richer JK (2021) MicroRNA-200c restoration reveals a cytokine profile to enhance M1 macrophage polarization in breast cancers. NPJ Breast Cancer 7: 64. PMID: 34045467
Rosas E, Roberts JT, O’Neill K, Christenson JL, Williams MM, Hanamura T, Spoelstra NS, Vahrenkamp JM, Gertz J, Richer JK (2021) A positive feedback loop between TGFβ and androgen receptor supports triple-negative breast cancer anoikis resistance. Endocrinology 162: bqaa226. doi: 10.1210/endocr/bqaa226. PMID: 33294922
Williams MM, Spoelstra NS, Arnesen S, O'Neill KI, Christenson JL, Reese J, Torkko KC, Goodspeed A, Rosas E, Hanamura T, Sams SB, Li Z, Oesterreich S, Riggins RB, Jacobsen BM, Elias A, Gertz J, Richer JK (2021) Steroid hormone receptor and infiltrating immune cell status reveals therapeutic vulnerabilities of ESR1 mutant breast cancer. Cancer Research 81: 732-746. PMID: 33184106
A complete list of publications can be found at:
https://www.ncbi.nlm.nih.gov/myncbi/1Pwi2nmdakiAr/bibliography/public/
